Develops PCR diagnostic tests for infectious diseases.
Jun 2026Revenue $721K/yrExpenses $49.7M/yr
No trendCash runway ≈ 2 months from Jun 2026
Figures by year
When will Co-Diagnostics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $721K and expenses $49.7M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $622K | $50.8M | −$50.2M |
| Dec 2024 | $3.92M | $44.0M | −$40.1M |
| Dec 2023 | $6.81M | $49.5M | −$42.7M |
| Dec 2022 | $34.2M | $61.2M | −$27.0M |
| Dec 2021 | $97.9M | $51.8M | $46.1M |
| Dec 2020 | $74.6M | $32.9M | $41.7M |
| Dec 2019 | $215K | $6.11M | −$5.89M |
| Dec 2018 | $39.9K | $6.16M | −$6.12M |
| Dec 2017 | $7.66K | $4.57M | −$4.56M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.